NHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
National Healthcare Corp (NHC) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The company has demonstrated strong financial growth, operates in a growing senior healthcare market, and has no significant negative catalysts. While technical indicators are mixed, the long-term growth potential and positive financial performance make it a solid investment choice.
The MACD is negative and contracting, indicating a lack of strong momentum. RSI is neutral at 53.487, suggesting no overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the current price is near the support level of 155.638, with resistance at 162.403. Overall, technical indicators are mixed but lean slightly positive.
Strong financial performance in 2025, with revenue growth of 16.1%, net income growth of 17.7%, and EPS growth of 17.5%.
Expansion in the senior healthcare market with 80 skilled nursing facilities and 10,329 beds.
Gross margin improvement to 36.61%, up 9.41% YoY.
Neutral sentiment from hedge funds and insiders, indicating no significant buying activity.
Lack of recent congress trading data or influential figure activity.
In 2025/Q4, revenue increased by 4.65% YoY to $386.51 million. Net income surged by 308.63% YoY to $24.85 million. EPS rose by 305.13% YoY to $1.58. Gross margin improved to 36.61%, up 9.41% YoY. Overall, the company demonstrated robust financial growth across key metrics.
No recent analyst rating or price target data available. Wall Street sentiment is neutral, with no significant pros or cons identified.
